FAME: 24-month Readout Shows Steady Improvement
Vision continued to significantly improve at 2 years with
the fluocinolone acetonide intravitreal insert (Iluvien,
Alimera Sciences), according to Baruch D. Kuppermann,
MD, PhD, who presented the 24-month readout of the
FAME trial at the American Academy of Ophthalmology
(AAO) annual meeting in Chicago.1
Iluvien is an...